Hair Removal: Intense Pulsed Light Versus Diode Laser

Status Not yet recruiting

Clinical Trial Summary

The goal of this clinical trial is to compare the effectiveness of two hair removal techniques: Intense Pulsed Light (IPL) and Diode Laser in woman underarm. . Main Questions: - Determine the thread count in a 4cm² quadrant in the central axillary region before each session, 4-6 weeks after the last session and at follow-up 30 weeks after the last session; - Measure the thickness of the hair before each session, 4-6 weeks after the last session and at follow-up 6 months after the last session; - Compare the level of pain during procedures; - Evaluate the volunteer's level of satisfaction after the end of the sessions programmed by the study; - Evaluate quality of life and self-image before and after the end of the sessions programmed by the study; - Evaluate the maintenance of results 6 months after the last procedure performed. Researchers will compare IPL and Diode laser to see if hair removal is similar at short and long time course. The IPL treatment will be applied to one axilla. The 800nm Diode Laser treatment will be applied to the other axilla. Treatment allocation will be randomized for each participant. Participants will undergo monthly sessions for four months, totaling four treatments. Follow-up assessments will occur 30 days and 6 months after the final session.

Clinical Trial Description

This is a randomized controlled trial of hair removal in axilla for women, being intense pulsed light compared to diode laser. The session frequency will be once a month for 4 months, totaling 4 treatments. There will be a follow-up at 30 days and 6 months after the end of the treatment. After the evaluations and photographs, the armpits will be cleaned with 0.5% alcoholic chlorhexidine and will be shaved with a disposable razor blade. Neutral water-based gel will be applied to the region to receive the treatment. Patients will be instructed not to perform any trichotomy procedures in the region during the research period. The treatment technique will be punctual where the applicator will be kept in full contact with the skin at 90° and moved to the next point after deposition of energy over the entire treatment area until the defined energy is delivered. The applicator tip will be cooled as much as the equipment allows. ;

Study Design

Related Conditions & MeSH terms

Hair Removal

Clinical Trial Details

NCT number	NCT06179186
Study type	Interventional
Source	University of Nove de Julho
Contact	Renata Taylor
Phone	+5511930902810
Email	renatataylor@uni9.edu.br
Status	Not yet recruiting
Phase	N/A
Start date	January 2024
Completion date	July 30, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00366964` - The Efficacy Of The Wavelight Mydon Laser for Hair Removal And Treatment of Leg Veins	N/A
Completed	`NCT04807205` - Post Market Study Using The Elite IQ Device	N/A
Completed	`NCT01578187` - Hair2Go Label Comprehension and Usability Study	N/A
Completed	`NCT01348789` - Safety for Frequent Use Conditions of Hair Removal Device	N/A
Completed	`NCT01348776` - The Efficiency of the Hair2Go Device: A Prospective, Open, Label Study With Before-After Design	N/A
Completed	`NCT01057134` - Ultrasound Device for Hair Removal
Completed	`NCT01282866` - Hair Count Reduction Verification Study With the LightSheer Duet HS Handpiece	N/A
Completed	`NCT01529931` - Long Term Efficiency of the Hair2Go Device	N/A
Completed	`NCT01801202` - Clinical Evaluation of LightSheer Duet 805nm HS Handpiece	N/A
Terminated	`NCT02912013` - The Efficacy of the Me Mini Device for Hair Removal	N/A
Active, not recruiting	`NCT02318654` - Ice Versus EMLA for Pain in Laser Hair Removal	N/A
Completed	`NCT03438929` - Evaluation of Diolaze XL Blended Mode for Hair Removal	N/A
Completed	`NCT03945383` - Clinical Investigation of Safety and Effectiveness of Emerald IPLdevice	N/A
Completed	`NCT03921814` - Sunstone IPL (Intense Pulsed Light) for Hair Reduction	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.